Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that causes a debilitating febrile illness characterized by persistent muscle and joint pain. The widespread distribution of transmission-competent vectors, Aedes species mosquitoes, indicates the potential risk of large-scale epidemics with high attack rates that can severely impact public health globally. Despite this, currently, there are no antivirals available for the treatment of CHIKV infections. Thus, we aimed to identify potential drug candidates by screening a chemical library using a cytopathic effect-based high-throughput screening assay. As a result, we identified radicicol, a heat-shock protein 90 (Hsp90) inhibitor that effectively suppressed CHIKV replication by blocking the synthesis of both positive- and negative-strand viral RNA as well as expression of viral proteins. Interestingly, selection for viral drug-resistant variants and mutational studies revealed nonstructural protein 2 (nsP2) as a putative molecular target of radicicol. Moreover, co-immunoprecipitation and in silico modeling analyses determined that G641D mutation in the methyltransferase (MT)-like domain of nsP2 is essential for its interaction with cytoplasmic Hsp90β chaperone. Our findings collectively support the potential application of radicicol as an anti-CHIKV agent. The detailed study of the underlying mechanism of action further contributes to understanding virus-host interactions for novel therapeutics against CHIKV infection.

Background Bovine ephemeral fever (BEF) is a viral disease in cattle and buffaloes, with subclinical involvement in various ruminant species. Objectives This study aimed to investigate bovine ephemeral fever virus (BEFV) transmission in deer in the Republic of Korea (ROK) and the potential risk factors associated with seropositivity. Methods We conducted a retrospective cross‐sectional serological survey of neutralising antibodies against BEFV in cervid sera collected from the ROK. Results The seroprevalence of BEFV was estimated to be 10.8% (95% confidence interval [CI] = 8.5–14.1), demonstrating that exposure to this virus is prevalent among farmed and free‐ranging cervids in the ROK. The results revealed that age class and geographic location affected seroprevalence. Older age and the presence of neighbouring ruminant farms were significant risk factors (odds ratio [OR] = 2.394, 95% CI = 1.195–4.796) and (OR = 1.533, 95% CI = 1.026–2.288), respectively. We also observed that the individual likelihood of positivity in the southern provinces was significantly higher than that in the northern provinces (OR = 1.744, 95% CI = 1.001–3.037). There were also significant differences in the seroprevalence of cervids between the western and eastern provinces (OR = 2.021, 95% CI = 1.047–3.900). Factors that were not significantly associated with BEFV antibody prevalence included herd size and species ( p > 0.05). Conclusions These results suggest that cervid species may serve as important reservoirs for the transmission of BEFV, highlighting the need for closer monitoring of BEFV infections in cervids in the ROK.

Aino virus is an infectious, non-contagious, vector-borne agent that has been implicated in arthrogryposis-hydranencephaly syndrome in newborn cattle, sheep, and goats. Information about reservoirs and host animal species susceptible to Aino virus remains unclear. To further explore the role of cervids in Aino virus infection transmission, we investigated cervid sera to determine the prevalence of Aino virus-neutralizing antibodies and to identify factors correlated with antibody positivity. We screened cervid serum samples collected in the Republic of Korea to better understand infection patterns in this animal species. Overall, Aino virus infection was widespread; 75 of 716 (10.5%, 95% [95% CI] = 8.4–13.4) farmed-cervid serum samples collected from 292 herds contained antibodies to Aino virus. Serological evidence of Aino virus infection was demonstrated in 5 of 43 free-ranging cervids, accounting for a prevalence rate of ~11.6% (95% CI = 4.6–26.4). Our results revealed that age class and geographic location affected seroprevalence. The main risk factors associated with Aino virus seroprevalence were older age (> 2 years old, OR = 2.221, 95% CI = 1.209–4.079, P = 0.009 in adults), southern provinces (OR = 2.432, 95% CI = 1.445–4.093, P = 0.001), and western provinces (OR = 1.905, 95% CI = 1.041–3.488, P = 0.034). The results in this study suggest that cervid species might serve as important hosts for the transmission of Aino virus, highlighting the need for careful monitoring of Aino virus infections in cervids.

Coxsackievirus B3 (CVB3) is a single-stranded RNA virus that belongs to the Enterovirus genus. CVB3 is a human pathogen associated with serious conditions such as myocarditis, dilated cardiomyopathy, and pancreatitis. However, there are no therapeutic interventions to treat CVB3 infections. In this study, we found that CVB3 induced metabolic alteration in host cells through increasing glycolysis level, as indicated by an increase in the extracellular acidification rate (ECAR). CVB3-mediated metabolic alteration was confirmed by metabolite change analysis using gas chromatography-mass spectrometry (GC-MS). Based on findings, a strategy to inhibit glycolysis has been proposed to treat CVB3 infection. Indeed, glycolysis inhibitors (2-Deoxy-D-glucose, sodium oxide) significantly reduced CVB3 titers after CVB3 infection, indicating that glycolysis inhibitors can be used as effective antiviral agents. Taken together, our results reveal a novel mechanism by which CVB3 infection is controlled by regulation of host cell metabolism.

Background: Bovine ephemeral fever virus (BEFV) is an arthropod-borne virus classified as a type species of the genus Ephemerovirus, family Rhabdoviridae. BEFV is the causative agent of bovine ephemeral fever (BEF), a non-contagious disease of acute febrile clinical signs in cattle and water buffalo. Some species might act as reservoir hosts, and antibodies to BEFV have also been found in asymptomatic sheep, goats, pigs, and many wild animals. This study aimed to conduct a retrospective cross-sectional serological screening in South Korea to address BEFV seroprevalence and identify risk factors for becoming seropositive for the virus in sheep and goats. Materials, Methods & Results: The apparent prevalence rates were considered to be the animal-level prevalence, defined as the proportion of serum neutralization test (SNT)-positive animals out of the total number of animals tested in the study area, and flock prevalence was defined as the proportion of SNT-positive flocks out of the total number of tested flocks in the area. A flock was classified as positive if at least one animal was SNT-positive. At the national level in 2011, 28 of 177 flocks (15.8%; 95% CI, 11.2−21.9%) and 71 of 498 heads (14.3%, 95% CI: 11.5-17.6%) that were analyzed showed serum neutralizing antibodies against BEFV. Our results revealed that age class, vector control, and geographic location affected seroprevalence to differing extents. In the univariate analysis, older age was a significant risk factor (OR, 2.327; 95% CI, 1.147-4.721; P = 0.017 in adults). The management risk factor attributes showed that preventive measures, such as routine application of insecticides in farms, decreased the odds of seropositivity for BEFV (OR, 0.514; 95% CI, 0.267-0.991; P = 0.044). Vector control was a significant protective factor, while animal species, flock size, and flock structure were not significantly associated. Differences in seroprevalence between variations in the presence of ruminant farms, lakes, or rice paddies within a 1-km radius or type of land use were not statistically significant (P > 0.05). We observed a significant difference in the individual likelihood of being positive in the southern provinces with respect to that in the northern provinces (OR, 2.166; 95% CI, 1.228-3.824; P = 0.007). Differences in seroprevalence between variations in the eastern and western regions were not statistically significant (P > 0.05). The retrospective study results showed that the virus was widely distributed in sheep and goats in South Korea, with seropositive rates ranging from 7.8% to 19.7% between 2003 and 2008.Discussion: This is the first report of circulating antibodies against BEFV in sheep and goats in South Korea. The serological prevalence of BEFV infection in sheep and goats was significantly different between different age cohorts, vector control, and geographical locations: it was higher in the older group and the southern and western regions of South Korea. Determination of seropositivity rates often leads to an understanding of virus circulation dynamics and is useful in the formulation of disease control measures. Our results demonstrated that vector control was a significant protective factor; therefore, the summer control of vectors could be better implemented in provinces with elevated seropositivity rates. The results of this seroprevalence study may serve as a basis for future epidemiological studies on BEFV infection in South Korea.